PROMETIC’S PLASMINOGEN (RYPLAZIM™) GRANTED ORPHAN DRUG DESIGNATION FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS (IPF)

December 18, 2017
Posted by: Fred Dumais
Posted In: Press Releases, Press Releases 2017
X